Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Debojyoti Halder
Observed name:
DEBOJYOTI HALDER
Institutions:
Birla Institute of Technology and Science - Hyderabad Campus,
Birla Institute of Technology and Science, Pilani
Observed institutions:
Manipal Academy of Higher Education,
Adamas University,
Birla Institute of Technology and Science - Hyderabad Campus,
Birla Institute of Technology and Science, Pilani
ORCID:
0000-0002-0007-550X
Observed ORCID:
0000-0002-0007-550X
OpenAlex ID:
A5079229918
Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study
2022
·
Debojyoti Halder
, Subham Das
, et al.
·
RSC Advances
·
57
PDF
Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha
2022
·
Debojyoti Halder
, Subham Das
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
41
Exploring the impact of trifluoromethyl (–CF 3 ) functional group on the anti-cancer activity of isoxazole-based molecules: design, synthesis, biological evaluation and molecular docking analysis
2024
·
Paramita Pattanayak
, Sripathi Nikhitha
, et al.
·
RSC Advances
·
40
PDF
Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations
2023
·
Debojyoti Halder
, Subham Das
, et al.
·
Molecular Diversity
·
27
Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer’s Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer’s Disease
2022
·
Subham Das
, Anu Kunnath Ramachandran
, et al.
·
CNS & Neurological Disorders - Drug Targets
·
16
Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer’s disease: an insight into structure-activity relationship
2022
·
Debojyoti Halder
, Subham Das
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
15
Molecular modeling to simulation: insights into Gaussian QSAR, molecular docking, and DFT for identification of HDAC3 inhibitors for neurocognitive vascular dementia
2025
·
Debojyoti Halder
, Suvankar Banerjee
, et al.
·
Scientific Reports
·
14
PDF
Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach
2025
·
Debojyoti Halder
, Shreya Mukherjee
, et al.
·
Scientific Reports
·
14
PDF
Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis
2024
·
Subham Das
, Debojyoti Halder
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
14
Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review
2022
·
Subham Das
, Shubham Roy
, et al.
·
Current Medicinal Chemistry
·
14
PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
2025
·
Ambati Himaja
, Debojyoti Halder
, et al.
·
ChemMedChem
·
9
PDF
An insight into structure-activity relationship of naturally derived biological macromolecules for the treatment of Alzheimer’s disease: a review
2023
·
Debojyoti Halder
, Subham Das
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
7
5-(Thiophen-2-yl)isoxazoles as novel anti-breast cancer agents targeting ERα: synthesis, in vitro biological evaluation, in silico studies, and molecular dynamics simulation
2025
·
Paramita Pattanayak
, Sripathi Nikhitha
, et al.
·
RSC Medicinal Chemistry
·
6
PDF
A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro Evaluation
2024
·
Debojyoti Halder
, R. S. Jeyaprakash
, et al.
·
Chemistry & Biodiversity
·
5
Solubility of drugs
2024
·
Sanjay Dey
, Debojyoti Halder
, et al.
·
Elsevier eBooks
·
1
Epigenetic modulators as therapeutics for neurodegenerative disorders/Alzheimer’s disease
2026
·
Debojyoti Halder
, Denish Prajapati
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
Author response for "5-(Thiophen-2-yl)isoxazoles as novel anti-breast cancer agents targeting ERα: Synthesis, in vitro biological evaluation, in silico studies, and molecular dynamics simulation"
2025
·
Paramita Pattanayak
, nikhitha sripathi
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
18
Citation count:
280
H-index:
10
I10-index:
10
Year
Topic
Type